Market Cap 413.99M
Revenue (ttm) 880,000.00
Net Income (ttm) -103.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -11,718.18%
Debt to Equity Ratio 0.00
Volume 1,591,000
Avg Vol 1,810,248
Day's Range N/A - N/A
Shares Out 114.05M
Stochastic %K 83%
Beta 1.74
Analysts Strong Sell
Price Target $12.79

Company Profile

Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a b...

Industry: Medical Devices
Sector: Healthcare
Phone: 206 676 0900
Address:
2401 Elliott Avenue, Suite 320, Seattle, United States
Alacrity2
Alacrity2 Jul. 4 at 3:33 PM
$CATX Happy Fourth of July twits!
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 2 at 2:33 PM
$CATX Built Over a Decade: The Only Fully Integrated Radiopharmaceutical Platform from Isotope to Patient
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 2 at 2:31 PM
$CATX Our pipeline of clinical candidates to differentiated targets provides broad coverage across the largest solid tumor populations with the highest unmet need: 250K+ addressable patients across 10+ tumor types
1 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 2 at 2:30 PM
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 2 at 2:29 PM
$CATX Pb-212 has the best overall profile !!!!!!!!!!!!
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 2 at 2:28 PM
$CATX a lot more data on the way for rest of 2026 !!!!!! KWYO !!!!!!!!!
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 2 at 2:27 PM
$CATX Optimizing the Entire System To unlock the full value of the radiopharmaceutical market, Perspective innovates every part of the chain
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 2 at 2:26 PM
$CATX Engineering the Alpha Advantage in Targeted Oncology
0 · Reply
Alacrity2
Alacrity2 Jul. 2 at 2:13 PM
$CATX very nice!
0 · Reply
Miura1957
Miura1957 Jul. 2 at 2:10 PM
$CATX don’t forget about 1/2 of the shares out have a cost basis of $3.79…I don’t think they will flip those shares for pennies…
0 · Reply
Latest News on CATX
Perspective Therapeutics Earnings release: Q1 2026

May 11, 2026, 4:00 PM EDT - 7 weeks ago

Perspective Therapeutics Earnings release: Q1 2026


Perspective Therapeutics Quarterly report: Q1 2026

May 11, 2026, 4:00 PM EDT - 7 weeks ago

Perspective Therapeutics Quarterly report: Q1 2026


Perspective Therapeutics Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 2 months ago

Perspective Therapeutics Proxy statement: Proxy filing


Perspective Therapeutics Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 2 months ago

Perspective Therapeutics Proxy statement: Proxy filing


Perspective Therapeutics Annual report: Q4 2025

Mar 16, 2026, 4:00 PM EDT - 3 months ago

Perspective Therapeutics Annual report: Q4 2025


Perspective Therapeutics Earnings release: Q4 2025

Mar 16, 2026, 4:00 PM EDT - 3 months ago

Perspective Therapeutics Earnings release: Q4 2025


Perspective Therapeutics assumed with a Buy at Truist

2025-11-24T14:00:51.000Z - 7 months ago

Perspective Therapeutics assumed with a Buy at Truist


Perspective Therapeutics Quarterly report: Q3 2025

Nov 10, 2025, 4:00 PM EST - 8 months ago

Perspective Therapeutics Quarterly report: Q3 2025


Perspective Therapeutics Earnings release: Q3 2025

Nov 10, 2025, 4:00 PM EST - 8 months ago

Perspective Therapeutics Earnings release: Q3 2025


Perspective Therapeutics Transcript: Study Update

Oct 20, 2025, 8:30 AM EDT - 9 months ago

Perspective Therapeutics Transcript: Study Update


Perspective Therapeutics Press release: Study Update

Oct 20, 2025, 8:30 AM EDT - 9 months ago

Perspective Therapeutics Press release: Study Update


Perspective Therapeutics Slides: Study Update

Oct 20, 2025, 8:30 AM EDT - 9 months ago

Perspective Therapeutics Slides: Study Update


Perspective Therapeutics Quarterly report: Q2 2025

Aug 13, 2025, 9:30 AM EDT - 11 months ago

Perspective Therapeutics Quarterly report: Q2 2025


Perspective Therapeutics Earnings release: Q2 2025

Aug 13, 2025, 9:30 AM EDT - 11 months ago

Perspective Therapeutics Earnings release: Q2 2025


Perspective Therapeutics Quarterly report: Q1 2025

May 12, 2025, 4:00 PM EDT - 1 year ago

Perspective Therapeutics Quarterly report: Q1 2025


Perspective Therapeutics Earnings release: Q1 2025

May 12, 2025, 4:00 PM EDT - 1 year ago

Perspective Therapeutics Earnings release: Q1 2025


Perspective Therapeutics Proxy statement: Proxy Filing

Apr 16, 2025, 8:00 AM EDT - 1 year ago

Perspective Therapeutics Proxy statement: Proxy Filing


Perspective Therapeutics Proxy statement: Proxy Filing

Apr 16, 2025, 8:00 AM EDT - 1 year ago

Perspective Therapeutics Proxy statement: Proxy Filing


Perspective Therapeutics Annual report: Q4 2024

Mar 26, 2025, 4:00 PM EDT - 1 year ago

Perspective Therapeutics Annual report: Q4 2024


Perspective Therapeutics Earnings release: Q4 2024

Mar 26, 2025, 4:00 PM EDT - 1 year ago

Perspective Therapeutics Earnings release: Q4 2024


Perspective Therapeutics Transcript: Status Update

Jan 24, 2025, 8:00 AM EST - 1 year ago

Perspective Therapeutics Transcript: Status Update


Perspective Therapeutics Press release: Status Update

Jan 24, 2025, 8:00 AM EST - 1 year ago

Perspective Therapeutics Press release: Status Update


Perspective Therapeutics Slides: Status Update

Jan 24, 2025, 8:00 AM EST - 1 year ago

Perspective Therapeutics Slides: Status Update


Perspective Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 4:00 PM EST - 1 year ago

Perspective Therapeutics Quarterly report: Q3 2024


Perspective Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 4:00 PM EST - 1 year ago

Perspective Therapeutics Earnings release: Q3 2024


Alacrity2
Alacrity2 Jul. 4 at 3:33 PM
$CATX Happy Fourth of July twits!
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 2 at 2:33 PM
$CATX Built Over a Decade: The Only Fully Integrated Radiopharmaceutical Platform from Isotope to Patient
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 2 at 2:31 PM
$CATX Our pipeline of clinical candidates to differentiated targets provides broad coverage across the largest solid tumor populations with the highest unmet need: 250K+ addressable patients across 10+ tumor types
1 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 2 at 2:30 PM
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 2 at 2:29 PM
$CATX Pb-212 has the best overall profile !!!!!!!!!!!!
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 2 at 2:28 PM
$CATX a lot more data on the way for rest of 2026 !!!!!! KWYO !!!!!!!!!
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 2 at 2:27 PM
$CATX Optimizing the Entire System To unlock the full value of the radiopharmaceutical market, Perspective innovates every part of the chain
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 2 at 2:26 PM
$CATX Engineering the Alpha Advantage in Targeted Oncology
0 · Reply
Alacrity2
Alacrity2 Jul. 2 at 2:13 PM
$CATX very nice!
0 · Reply
Miura1957
Miura1957 Jul. 2 at 2:10 PM
$CATX don’t forget about 1/2 of the shares out have a cost basis of $3.79…I don’t think they will flip those shares for pennies…
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 1 at 10:37 PM
$CATX https://s3.amazonaws.com/sec.irpass.cc/2508/0001193125-26-292547.htm
0 · Reply
Jcljack26
Jcljack26 Jul. 1 at 5:10 PM
$CATX https://seekingalpha.com/news/4609158-btig-s-top-small-and-mid-cap-stocks-for-h2-ranked-by-sa-quant?utm_content=link-1&position=rta_news_sublogic_pretestlaunch_main_0_title&utm_source=seeking_alpha&utm_campaign=rta-stock-news&messageid=2900&mailingid=46391013&serial=46391013.50259&utm_term=46391013.50259&source=email_2900&utm_medium=emailhttps://seekingalpha.com/news/4609158-btig-s-top-small-and-mid-cap-stocks-for-h2-ranked-by-sa-quant?utm_content=link-1&position=rta_news_sublogic_pretestlaunch_main_0_title&utm_source=seeking_alpha&utm_campaign=rta-stock-news&messageid=2900&mailingid=46391013&serial=46391013.50259&utm_term=46391013.50259&source=email_2900&utm_medium=email
3 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 1 at 4:35 PM
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 1 at 3:55 PM
$CATX https://jnm.snmjournals.org/content/67/6/910
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 1 at 3:55 PM
0 · Reply
Satann
Satann Jul. 1 at 2:23 PM
0 · Reply
JDinvestments
JDinvestments Jul. 1 at 2:02 PM
$CATX more than likely BIG PHARMA sniffing around like a dog in heat 🔥🔥🔥🔥 STRONG BUYOUT 💰💰💰🚀🚀🚀🚀🚀🚀👋👋👋🤡🤡🤡
0 · Reply
David_M_
David_M_ Jul. 1 at 1:58 PM
0 · Reply
JDinvestments
JDinvestments Jul. 1 at 1:47 PM
$CATX crazy big boys and insiders own over 80% STRONG BUYOUT 💰💰💰🚀🚀🚀🚀🚀🚀 👋👋👋🤡🤡🤡
0 · Reply
JDinvestments
JDinvestments Jul. 1 at 1:39 PM
$CATX drop the hammer morty the moron !!! Do it 🔥🔥🔥 STRONG BUYOUT 💰💰💰🚀🚀🚀🚀🚀🚀
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jun. 30 at 10:01 PM
$CATX millennium management
2 · Reply
srod1122
srod1122 Jun. 30 at 7:55 PM
$CATX kidding me with this drop?
0 · Reply